All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Critics question consent, clinical utility, and industry influence in UK's Our Future Health programme

By

McCartney M, Cohen D.

5d ago· 13 min readenNews

Summary

The BMJ investigates concerns about the UK's Our Future Health (OFH) programme, the country's largest ever health research initiative with 1.5 million participants and a goal of 5 million. While praised for its scale and inclusion of underrepresented groups, critics raise serious issues around informed consent, the use of genetic data, potential undue inducement via £10 vouchers, the return of polygenic risk scores with unclear clinical utility, and questions about who truly benefits from this industry-and-government-backed database behind an NHS-branded facade.

Source

Twitter / XCritics question consent, clinical utility, and industry influence in UK's Our Future Health programmebmj.com

Key quotes

· 5 pulled
Described by one observer as the UK Biobank 'on steroids,' OFH has become the UK's largest ever health research programme, recruiting more than 1.5 million participants in just two years
Privacy campaigners have questioned whether participants truly understand how their genetic material will be used and whether the gift voucher could amount to undue inducement
Others warn of the risks associated with returning complex polygenic risk scores of dubious clinical utility, especially in the absence of a clear NHS plan
Participants are told that their data, along with access to their NHS records, will help researchers make discoveries about conditions such as dementia, cancer, and heart disease
Behind the headline data, however, concerns persist
Snippet from the RSS feed
The UK’s flagship health research programme promises breakthroughs, but beneath an NHS branded facade, critics are asking who really benefits from this vast database, heavily backed by industry and government. Margaret McCartney and Deborah Cohen investig

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.